Professor Brendan Buckley

Prof. Brendan Buckley is a medical graduate of University College Cork and a doctoral graduate of Oxford University.

For most of his career he worked in academic clinical practice as a consultant physician. He holds professorial titles in the faculties of Medicine at Universities in Cork and Dublin.

He has over 30 years’ experience in clinical research in roles as chief investigator, chair of data and safety monitoring committees and on institutional review boards. He became Chief Medical Officer of ICON plc, following their acquisition of Firecrest Clinical Ltd, which he had co-founded.

He was a member of ICON plc’s Executive Leadership Team and was actively involved in M&A targeting, assessment and diligence. Firecrest was one of a number of companies focused on clinical trial innovation which he co-founded and sold.

Brendan was a non-executive director of the Irish national medicines regulatory authority (now the Health Products Regulatory Authority) between 2004 and 2011.

He was a member of the inaugural European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) and of the EMA Scientific Advisory Group for Diabetes and Endocrinology as well as teaching on FDA advanced courses on clinical trials. He serves on the boards of various pharma development and services companies, some of which he has co-founded.

Brendan has written over 150 scientific publications, including the key opinion-leading book ‘Re-Engineering Clinical Trials’.